{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:53:59Z","timestamp":1772607239311,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.wneu.2021.11.104","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T02:28:15Z","timestamp":1637980095000},"page":"e880-e888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-1556","authenticated-orcid":false,"given":"Jinbing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxue","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.11.104_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2021.11.104_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","article-title":"Moyamoya disease in China: its clinical features and outcomes","volume":"43","author":"Duan","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.11.104_bib3","first-page":"1785","article-title":"Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis","volume":"128","author":"Deng","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.11.104_bib4","first-page":"3570","article-title":"Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: a retrospective study of 76 procedures","volume":"15","author":"Zhao","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.wneu.2021.11.104_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986732304160204181543","article-title":"Vasculogenic and angiogenic pathways in moyamoya disease","volume":"23","author":"Bedini","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.wneu.2021.11.104_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneph.2016.51","article-title":"Long noncoding RNAs in kidney and cardiovascular diseases","volume":"12","author":"Lorenzen","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.wneu.2021.11.104_bib7","article-title":"Altered lncRNAs transcriptomic profiles in atherosclerosis-induced ischemic stroke","author":"Ruan","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.wneu.2021.11.104_bib8","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.1038\/cddis.2016.145","article-title":"Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction","volume":"7","author":"Shan","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.wneu.2021.11.104_bib9","doi-asserted-by":"crossref","first-page":"42421","DOI":"10.1038\/srep42421","article-title":"Integrated analysis of lncRNA-mRNA co-expression profiles in patients with moyamoya disease","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.11.104_bib10","doi-asserted-by":"crossref","first-page":"e102382","DOI":"10.1371\/journal.pone.0102382","article-title":"Serum miRNA signature in moyamoya disease","volume":"9","author":"Dai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.11.104_bib11","doi-asserted-by":"crossref","first-page":"e0221811","DOI":"10.1371\/journal.pone.0221811","article-title":"Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders","volume":"14","author":"Peng","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.11.104_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.wneu.2016.05.081","article-title":"Long noncoding RNAs and their regulatory network: potential therapeutic targets for adult moyamoya disease","volume":"93","author":"Gao","year":"2016","journal-title":"World Neurosurg"},{"issue":"suppl 2","key":"10.1016\/j.wneu.2021.11.104_bib13","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S0303-8467(97)00046-2","article-title":"Development of intimal thickening in superficial temporal arteries in patients with moyamoya disease","volume":"99","author":"Aoyagi","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2021.11.104_bib14","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/01.STR.27.10.1750","article-title":"Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease","volume":"27","author":"Aoyagi","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2021.11.104_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11596-016-1677-5","article-title":"Histopathological features of middle cerebral artery and superficial temporal artery from patients with moyamoya disease and enlightenments on clinical treatment","volume":"36","author":"Sun","year":"2016","journal-title":"J\u00a0Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.wneu.2021.11.104_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1096\/fj.201900394RRR","article-title":"The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.wneu.2021.11.104_bib17","doi-asserted-by":"crossref","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","article-title":"Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.11.104_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A\u00a0genome-wide association study identifies RNF213 as the first moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J\u00a0Hum Genet"},{"issue":"suppl","key":"10.1016\/j.wneu.2021.11.104_bib19","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1440-1789.2000.00300.x","article-title":"Moyamoya disease","volume":"20","author":"Fukui","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.wneu.2021.11.104_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cca.2017.06.017","article-title":"Wnt5a and its signaling pathway in angiogenesis","volume":"471","author":"Shi","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2021.11.104_bib21","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e06-04-0320","article-title":"Wnt5a signaling induces proliferation and survival of endothelial cells in\u00a0vitro and expression of MMP-1 and Tie-2","volume":"17","author":"Masckauchan","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.wneu.2021.11.104_bib22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1242\/dev.104422","article-title":"Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis","volume":"141","author":"Korn","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.wneu.2021.11.104_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cytogfr.2013.05.009","article-title":"The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease","volume":"24","author":"Moss","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.wneu.2021.11.104_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12272-015-0652-1","article-title":"Cornin increases angiogenesis and improves functional recovery after stroke via the Ang1\/Tie2 axis and the Wnt\/beta-catenin pathway","volume":"39","author":"Xu","year":"2016","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.wneu.2021.11.104_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-319-89512-3_16","article-title":"Control of blood vessel formation by notch signaling","volume":"1066","author":"Tetzlaff","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.wneu.2021.11.104_bib26","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.celrep.2017.01.014","article-title":"FGF21 administration suppresses retinal and choroidal neovascularization in mice","volume":"18","author":"Fu","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.wneu.2021.11.104_bib27","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1056\/NEJMoa071906","article-title":"COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps","volume":"357","author":"Plaisier","year":"2007","journal-title":"N\u00a0Engl J Med"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021018076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021018076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:11:17Z","timestamp":1761815477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021018076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":27,"alternative-id":["S1878875021018076"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.11.104","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.11.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}